“PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY”, Вопр. онкол., vol. 66, no. 2, pp. 135–142, Feb. 2020, doi: 10.37469/0507-3758-2020-66-2-135-142.